We found that the weakly invasive breast cancer cell lines BT-474 and MCF-7, and the highly invasive cell line MDA-MB-231, express significantly higher levels of ARL13B mRNA when compared with the in situ breast cancer cell line MCF10DCIS.com (Figure 5A). The gene discussed is ARL13B; the disease is breast carcinoma.